Compassionate Use of Stanate (TM) [Stannsoporfin]
| Status: | No longer available |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 12/14/2016 |
| Start Date: | October 2003 |
Compassionate Use of Stannsoporfin as an Adjuvant to Phototherapy to Reduce the Need for Exchange Transfusions
The purpose of this protocol is to make Stanate (TM) [stannsoporfin, tin-mesoporphyrin]
available to infants who meet the following criteria:
1. the infant has a very high level of bilirubin without an adequate clinical response to
phototherapy;
2. the infant requires an exchange transfusion; and
3. the family refuses to allow the administration of blood products, particularly on
religious grounds, such as within the Jehovah's Witness community.
available to infants who meet the following criteria:
1. the infant has a very high level of bilirubin without an adequate clinical response to
phototherapy;
2. the infant requires an exchange transfusion; and
3. the family refuses to allow the administration of blood products, particularly on
religious grounds, such as within the Jehovah's Witness community.
- Term or near term neonate
- Elevated serum bilirubin
- Failing phototherapy
- Requires exchange transfusion
- Family refuses exchange transfusion on religious grounds
We found this trial at
1
site
Click here to add this to my saved trials
